222 related articles for article (PubMed ID: 30045780)
1. Impact of human cytomegalovirus on glioblastoma cell viability and chemotherapy treatment.
Dos Santos CJ; Ferreira Castro FL; de Aguiar RB; Menezes IG; Santos AC; Paulus C; Nevels M; Carlan da Silva MC
J Gen Virol; 2018 Sep; 99(9):1274-1285. PubMed ID: 30045780
[TBL] [Abstract][Full Text] [Related]
2. Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide.
Singh P; Neumann DM
Virus Res; 2020 Jan; 276():197829. PubMed ID: 31790777
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Reprogramming of Glioblastoma Cells during HCMV Infection Induces Secretome-Mediated Paracrine Effects in the Microenvironment.
Harrison MAA; Hochreiner EM; Benjamin BP; Lawler SE; Zwezdaryk KJ
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062307
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus gene expression in long-term infected glioma stem cells.
Fiallos E; Judkins J; Matlaf L; Prichard M; Dittmer D; Cobbs C; Soroceanu L
PLoS One; 2014; 9(12):e116178. PubMed ID: 25549333
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects.
Cobbs CS
Curr Opin Oncol; 2013 Nov; 25(6):682-8. PubMed ID: 24097102
[TBL] [Abstract][Full Text] [Related]
6. Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples.
Ranganathan P; Clark PA; Kuo JS; Salamat MS; Kalejta RF
J Virol; 2012 Jan; 86(2):854-64. PubMed ID: 22090104
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
8. The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus.
Jault FM; Spector SA; Spector DH
J Virol; 1994 Feb; 68(2):959-73. PubMed ID: 8289398
[TBL] [Abstract][Full Text] [Related]
9. Isofuranodiene synergizes with temozolomide in inducing glioma cells death.
Brunetti A; Marinelli O; Morelli MB; Iannarelli R; Amantini C; Russotti D; Santoni G; Maggi F; Nabissi M
Phytomedicine; 2019 Jan; 52():51-59. PubMed ID: 30599912
[TBL] [Abstract][Full Text] [Related]
10. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
11. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.
Fornara O; Bartek J; Rahbar A; Odeberg J; Khan Z; Peredo I; Hamerlik P; Bartek J; Stragliotto G; Landázuri N; Söderberg-Nauclér C
Cell Death Differ; 2016 Feb; 23(2):261-9. PubMed ID: 26138445
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus may promote tumour progression by upregulating arginase-2.
Costa H; Xu X; Overbeek G; Vasaikar S; Patro CP; Kostopoulou ON; Jung M; Shafi G; Ananthaseshan S; Tsipras G; Davoudi B; Mohammad AA; Lam H; Strååt K; Wilhelmi V; Shang M; Tegner J; Tong JC; Wong KT; Söderberg-Naucler C; Yaiw KC
Oncotarget; 2016 Jul; 7(30):47221-47231. PubMed ID: 27363017
[TBL] [Abstract][Full Text] [Related]
14. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.
Cobbs CS; Soroceanu L; Denham S; Zhang W; Kraus MH
Cancer Res; 2008 Feb; 68(3):724-30. PubMed ID: 18245472
[TBL] [Abstract][Full Text] [Related]
15. Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration.
Ahmadi-Zeidabadi M; Akbarnejad Z; Esmaeeli M; Masoumi-Ardakani Y; Mohammadipoor-Ghasemabad L; Eskandary H
Electromagn Biol Med; 2019; 38(3):198-209. PubMed ID: 31179753
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
Jeong H; Park J; Shim JK; Lee JE; Kim NH; Kim HS; Chang JH; Yook JI; Kang SG
J Neurooncol; 2019 May; 143(1):69-77. PubMed ID: 30887242
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival.
Rahbar A; Orrego A; Peredo I; Dzabic M; Wolmer-Solberg N; Strååt K; Stragliotto G; Söderberg-Nauclér C
J Clin Virol; 2013 May; 57(1):36-42. PubMed ID: 23391370
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype.
Soroceanu L; Matlaf L; Bezrookove V; Harkins L; Martinez R; Greene M; Soteropoulos P; Cobbs CS
Cancer Res; 2011 Nov; 71(21):6643-53. PubMed ID: 21900396
[TBL] [Abstract][Full Text] [Related]
19. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.
Mitchell DA; Xie W; Schmittling R; Learn C; Friedman A; McLendon RE; Sampson JH
Neuro Oncol; 2008 Feb; 10(1):10-8. PubMed ID: 17951512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]